2012-12-01
Functional differences between human NKp44- and NKp44+ RORC+ innate lymphoid cells
Publication
Publication
Frontiers in Immunology , Volume 3 - Issue APR
Human RORC+ lymphoid tissue inducer cells are part of a rapidly expanding family of innate lymphoid cells (ILC) that participate in innate and adaptive immune responses as well as in lymphoid tissue (re) modeling. The assessment of a potential role for innate lymphocyte-derived cytokines in human homeostasis and disease is hampered by a poor characterization of RORC+ innate cell subsets and a lack of knowledge on the distribution of these cells in adults. Here we show that functionally distinct subsets of human RORC+ innate lymphoid cells are enriched for secretion of IL-17a or IL-22. Both subsets have an activated phenotype and can be distinguished based on the presence or absence of the natural cytotoxicity receptor NKp44. NKp44+ IL-22 producing cells are present in tonsils while NKp44- IL-17a producing cells are present in fetal developing lymph nodes. Development of human intestinal NKp44+ ILC is a programmed event that is independent of bacterial colonization and these cells colonize the fetal intestine during the first trimester. In the adult intestine, NKp44+ ILC are the main ILC subset producing IL-22. NKp44- ILC remain present throughout adulthood in peripheral non-inflamed lymph nodes as resting, non-cytokine producing cells. However, upon stimulation lymph node ILC can swiftly initiate cytokine transcription suggesting that secondary human lymphoid organs may function as a reservoir for innate lymphoid cells capable of participating in inflammatory responses.
Additional Metadata | |
---|---|
, , , , , , , | |
doi.org/10.3389/fimmu.2012.00072, hdl.handle.net/1765/74867 | |
Frontiers in Immunology | |
Organisation | Department of Surgery |
Hoorweg, K., Peters, C., Cornelissen, F., Aparicio-Domingo, P., Papazian, N., Kazemier, G., … Cupedo, T. (2012). Functional differences between human NKp44- and NKp44+ RORC+ innate lymphoid cells. Frontiers in Immunology, 3(APR). doi:10.3389/fimmu.2012.00072 |